Document:

THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN AN AGREEMENT, NEITHER THIS WARRANT NOR ANY OF SUCH
SHARES MAY BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER SAID
ACT OR, AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE, REASONABLY ACCEPTABLE TO THE COMPANY’S COUNSEL, THAT REGISTRATION
IS NOT REQUIRED UNDER SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 OR REGULATIONS UNDER SUCH ACT.

 

Right to Purchase 2,000,000 Shares of
Common Stock, par value $.01 per share

 

STOCK PURCHASE WARRANT

 

THIS
CERTIFIES THAT, for value received, William S. Rees, Jr., or his registered assigns, is entitled to purchase from
VANTAGE HEALTH, a Nevada corporation (the “Company”), at any time or from time to time during the period
specified in Paragraph 2 hereof, 2,000,000 fully paid and non assessable shares of the Company’s Common
Stock, par value $.01 per share (the “Common Stock”), at an exercise price per share equal to $0.05 (the
“Exercise Price”). The term “Warrant Shares,” as used herein, refers to the shares of Common Stock
purchasable hereunder. The Warrant Shares and the Exercise Price are subject to adjustment as provided in Paragraph 4 hereof.
The term “Warrants” means this Warrant, by and among the Company and the Entity listed on the execution page
thereof. This Warrant is subject to the following terms, provisions, and conditions:

 

		1.	Manner of Exercise; Issuance of Certificates; Payment
for Shares.

 

Subject to the provisions hereof, this Warrant may be exercised
by the holder hereof, in whole or in part, by the surrender of this Warrant, together with a completed exercise agreement in the
form attached hereto (the “Exercise Agreement”), to the Company during normal business hours on any business day at
the Company’s principal executive offices (or such other office or agency of the Company as it may designate by notice to
the holder hereof), and upon payment to the Company in cash, by certified or official bank check or by wire transfer for the account
of the Company of the Exercise Price for the Warrant Shares specified in the Exercise Agreement or, if the resale of the Warrant
Shares by the holder is not then registered pursuant to an effective registration statement under the Securities Act of 1933, as
amended (the “Securities Act”), or an exemption from registration is not available for the resale of the Warrant Shares,
delivery to the Company of a written notice of an election to effect a “Cashless Exercise” (as defined in Section 10(c)
below) for the Warrant Shares specified in the Exercise Agreement. The Warrant Shares so purchased shall be deemed to be issued
to the holder hereof or such holder’s designee, as the record owner of such shares, as of the close of business on the date
on which this Warrant shall have been surrendered, the completed Exercise Agreement shall have been delivered, and payment shall
have been made for such shares as set forth above. In no event shall the Company be obligated to pay to the Holder any cash or
other consideration or otherwise “net cash settle” this Warrant. Certificates for the Warrant Shares so purchased,
representing the aggregate number of shares specified in the Exercise Agreement, shall be delivered to the holder hereof within
a reasonable time, not exceeding five (5) business days, after this Warrant shall have been so exercised. The certificates so delivered
shall be in such denominations as may be requested by the holder hereof and shall be registered in the name of such holder or such
other name as shall be designated by such holder. If this Warrant shall have been exercised only in part, then, unless this Warrant
has expired, the Company shall, at its expense, at the time of delivery of such certificates, deliver to the holder a new Warrant
representing the number of shares with respect to which this Warrant shall not then have been exercised.

 

    	 

    	 

    

 

Notwithstanding anything in this Warrant to the
contrary, in no event shall the holder of this Warrant be entitled to exercise a number of Warrants (or portions thereof) in excess
of the number of Warrants (or portions thereof) upon exercise of which the sum of (i) the number of shares of Common Stock beneficially
owned by the holder and its affiliates (other than shares of Common Stock which may be deemed beneficially owned through the ownership
of the unexercised Warrants and the unexercised or unconverted portion of any other securities of the Company (including the Notes
(as defined in the Securities Purchase Agreement)) subject to a limitation on conversion or exercise analogous to the limitation
contained herein) and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants (or portions thereof) with
respect to which the determination described herein is being made, would result in beneficial ownership by the holder and its affiliates
of more than 4.9% of the outstanding shares of Common Stock. For purposes of the immediately preceding sentence, beneficial ownership
shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13D-G thereunder,
except as otherwise provided in clause (i) of the preceding sentence. Notwithstanding anything to the contrary contained herein,
the limitation on exercise of this Warrant set forth herein may not be amended without the written consent of the holder hereof
and the Company.

 

	 	2.	Period of Exercise.

 

This Warrant is exercisable at any time or from
time to time on or after the date herein and before 5:00 p.m., New York, New York time on the fifth (5th) anniversary
of the date of issuance (the “Exercise Period”).

 

	 	3.	Certain Agreements of the Company.

 

The Company hereby covenants and agrees as follows:

 

(a)                
Shares to be Fully Paid. All Warrant Shares
will, upon issuance in accordance with the terms of this Warrant, be validly issued, fully paid, and non assessable and free from
all taxes, liens, and charges with respect to the issue thereof.

 

    	-2-

    	 

    

 

(b)                
Reservation of Shares. During the Exercise
Period, the Company shall at all times have authorized, and reserved for the purpose of issuance upon exercise of this Warrant,
a sufficient number of shares of Common Stock to provide for the exercise of this Warrant.

 

(c)                
Listing. The Company shall promptly secure
the listing of the shares of Common Stock issuable upon exercise of the Warrant upon each national securities exchange or automated
quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance upon exercise
of this Warrant) and shall maintain, so long as any other shares of Common Stock shall be so listed, such listing of all shares
of Common Stock from time to time issuable upon the exercise of this Warrant; and the Company shall so list on each national securities
exchange or automated quotation system, as the case may be, and shall maintain such listing of, any other shares of capital stock
of the Company issuable upon the exercise of this Warrant if and so long as any shares of the same class shall be listed on such
national securities exchange or automated quotation system.

 

(d)                
Certain Actions Prohibited. The Company will
not, by amendment of its charter or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to
be observed or performed by it hereunder, but will at all times in good faith assist in the carrying out of all the provisions
of this Warrant and in the taking of all such action as may reasonably be requested by the holder of this Warrant in order to protect
the exercise privilege of the holder of this Warrant against dilution or other impairment, consistent with the tenor and purpose
of this Warrant. Without limiting the generality of the foregoing, the Company (i) will not increase the par value of any shares
of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in effect, and (ii) will take all such
actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable
shares of Common Stock upon the exercise of this Warrant.

 

(e)                
Successors and Assigns. This Warrant will
be binding upon any entity succeeding to the Company by merger, consolidation, or acquisition of all or substantially all the Company’s
assets.

 

	 	4.	Adjustment of Exercise Price and Shares.

 

During the Exercise Period, the Exercise Price
and the number of Warrant Shares shall be subject to adjustment from time to time as provided in this Paragraph 4.

 

In the event that any adjustment of the Exercise
Price as required herein results in a fraction of a cent, such Exercise Price shall be rounded up to the nearest cent.

 

(a)                
Subdivision or Combination of Common Stock.
If the Company at any time subdivides (by any stock split, stock dividend, recapitalization, reorganization, reclassification or
other similar transaction) the shares of Common Stock acquirable hereunder into a greater number of shares, then, after the date
of record for effecting such subdivision, the number of shares available for purchase and the corresponding Exercise Price in effect
immediately prior to such subdivision will be proportionately reduced. If the Company at any time combines (by reverse stock split,
recapitalization, reorganization, reclassification or other similar transaction) the shares of Common Stock acquirable hereunder
into a smaller number of shares, then, after the date of record for effecting such combination, the number of shares available
for purchase and the corresponding Exercise Price in effect immediately prior to such combination will be proportionately increased.

 

    	-3-

    	 

    

 

(b)                
Consolidation, Merger or Sale. In case of
any consolidation of the Company with, or merger of the Company into any other corporation, or in case of any sale or conveyance
of all or substantially all of the assets of the Company other than in connection with a plan of complete liquidation of the Company,
then as a condition of such consolidation, merger or sale or conveyance, adequate provision will be made whereby the holder of
this Warrant will have the right to acquire and receive, at the Company’s option and in its sole discretion, either (a) upon
exercise of this Warrant in lieu of the shares of Common Stock immediately theretofore acquirable upon the exercise of this Warrant,
such shares of stock, securities or assets as may be issued or payable with respect to or in exchange for the number of shares
of Common Stock immediately theretofore acquirable and receivable upon exercise of this Warrant had such consolidation, merger
or sale or conveyance not taken place or (b) cash equal to the value of the Warrant as determined in accordance with the Black-Scholes
option pricing formula. In any such case, the Company will make appropriate provision to insure that the provisions of this Paragraph
4 hereof will thereafter be applicable as nearly as may be in relation to any shares of stock or securities thereafter deliverable
upon the exercise of this Warrant. The Company will not effect any consolidation, merger or sale or conveyance unless prior to
the consummation thereof, the successor corporation (if other than the Company) assumes by written instrument the obligations under
this Paragraph 4 and the obligations to deliver to the holder of this Warrant such shares of stock, securities or assets as, in
accordance with the foregoing provisions, the holder may be entitled to acquire.

 

(c)                
Distribution of Assets. In case the Company
shall declare or make any distribution of its assets (including cash) to holders of Common Stock as a partial liquidating dividend,
by way of return of capital or otherwise, then, after the date of record for determining shareholders entitled to such distribution,
but prior to the date of distribution, the holder of this Warrant shall be entitled upon exercise of this Warrant for the purchase
of any or all of the shares of Common Stock subject hereto, to receive the amount of such assets which would have been payable
to the holder had such holder been the holder of such shares of Common Stock on the record date for the determination of shareholders
entitled to such distribution.

 

(d)                
No Fractional Shares. No fractional shares
shall be issued upon the exercise of this Warrant as a consequence of any adjustment pursuant hereto. All Warrant Shares (including
fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result
in the issuance of any fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share,
the number of Warrant Shares to be issued will be rounded up to the nearest whole share.

 

(e)                
Other Notices. In case at any time:

 

(i)                 
the Company shall declare any dividend upon the Common Stock payable in shares of stock
of any class or make any other distribution (including dividends or distributions payable in cash out of retained earnings) to
the holders of the Common Stock;

 

    	-4-

    	 

    

 

(ii)               
there shall be any capital reorganization of the Company, or reclassification of the Common
Stock, or consolidation or merger of the Company with or into, or sale of all or substantially all its assets to, another corporation
or entity; or

 

(iii)              there
shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company;

 

then, in each such case, the
Company shall give to the holder of this Warrant (a) notice of the date on which the books of the Company shall close or a
record shall be taken for determining the holders of Common Stock entitled to receive any such dividend, distribution, or
subscription rights or for determining the holders of Common Stock entitled to vote in respect of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up and (b) in the case of any such
reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, notice of the date
(or, if not then known, a reasonable approximation thereof by the Company) when the same shall take place. Such notice
shall also specify the date on which the holders of Common Stock shall be entitled to receive such dividend, distribution, or
subscription rights or to exchange their Common Stock for stock or other securities or property deliverable upon such
reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation, or winding-up, as the case may be.
Such notice shall be given at least 30 days prior to the record date or the date on which the Company’s books are
closed in respect thereto. Failure to give any such notice or any defect therein shall not affect the validity of the
proceedings referred to in clauses (i), (ii), (iii) and (iv) above.

 

(f)                 
Certain Definitions.

 

(i)                 
“Common Stock Deemed Outstanding”
shall mean the number of shares of Common Stock actually outstanding (not including shares of Common Stock held in the treasury
of the Company), plus (x) pursuant to Paragraph 4(b)(i) hereof, the maximum total number of shares of Common Stock issuable upon
the exercise of Options, as of the date of such issuance or grant of such Options, if any, and (y) pursuant to Paragraph 4(b)(ii)
hereof, the maximum total number of shares of Common Stock issuable upon conversion or exchange of Convertible Securities, as of
the date of issuance of such Convertible Securities, if any.

 

(ii)               
“Market Price,” as of any date,
(i) means the average of the last reported sale prices for the shares of Common Stock on the OTCBB or the “pink sheets”
for the five (5) Trading Days immediately preceding such date as reported by Bloomberg, or (ii) if the OTCBB or the “pink
sheets” is not the principal trading market for the shares of Common Stock, the average of the last reported sale prices
on the principal trading market for the Common Stock during the same period as reported by Bloomberg, or (iii) if market value
cannot be calculated as of such date on any of the foregoing bases, the Market Price shall be the fair market value as reasonably
determined in good faith by (a) the Board of Directors of the Company or, at the option of a majority-in-interest of the holders
of the outstanding Warrants by (b) an independent investment bank of nationally recognized standing in the valuation of businesses
similar to the business of the corporation. The manner of determining the Market Price of the Common Stock set forth in the foregoing
definition shall apply with respect to any other security in respect of which a determination as to market value must be made hereunder.

 

    	-5-

    	 

    

 

(iii)             
“Common Stock,” for purposes of
this Paragraph 4, includes the Common Stock, par value $.01 per share, and any additional class of stock of the Company having
no preference as to dividends or distributions on liquidation, provided that the shares purchasable pursuant to this Warrant shall
include only shares of Common Stock, par value $.01 per share, in respect of which this Warrant is exercisable, or shares resulting
from any subdivision or combination of such Common Stock, or in the case of any reorganization, reclassification, consolidation,
merger, or sale of the character referred to in Paragraph 4(e) hereof, the stock or other securities or property provided for in
such Paragraph.

 

	 	5.	Issue Tax.

 

The issuance of certificates for Warrant Shares
upon the exercise of this Warrant shall be made without charge to the holder of this Warrant or such shares for any issuance tax
or other costs in respect thereof, provided that the Company shall not be required to pay any tax which may be payable in respect
of any transfer involved in the issuance and delivery of any certificate in a name other than the holder of this Warrant.

 

	 	6.	No Rights or Liabilities as a Shareholder.

 

This Warrant shall not entitle the holder hereof
to any voting rights or other rights as a shareholder of the Company. No provision of this Warrant, in the absence of affirmative
action by the holder hereof to purchase Warrant Shares, and no mere enumeration herein of the rights or privileges of the holder
hereof, shall give rise to any liability of such holder for the Exercise Price or as a shareholder of the Company, whether such
liability is asserted by the Company or by creditors of the Company.

 

	 	7.	Transfer, Exchange, and Replacement of Warrant.

 

(a)                
Restriction on Transfer. This Warrant and
the rights granted to the holder hereof are transferable, in whole or in part, upon surrender of this Warrant, together with a
properly executed assignment in the form attached hereto, at the office or agency of the Company referred to in Paragraph 7(e)
below, provided, however, that any transfer or assignment shall be subject to the conditions set forth in Paragraph 7(f) hereof
and to the applicable provisions of the Securities Purchase Agreement. Until due presentment for registration of transfer on the
books of the Company, the Company may treat the registered holder hereof as the owner and holder hereof for all purposes, and the
Company shall not be affected by any notice to the contrary.

 

(b)                
Warrant Exchangeable for Different Denominations.
This Warrant is exchangeable, upon the surrender hereof by the holder hereof at the office or agency of the Company referred to
in Paragraph 7(e) below, for new Warrants of like tenor representing in the aggregate the right to purchase the number of shares
of Common Stock which may be purchased hereunder, each of such new Warrants to represent the right to purchase such number of shares
as shall be designated by the holder hereof at the time of such surrender.

 

(c)                
Replacement of Warrant. Upon receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction, or mutilation of this Warrant and, in the case of any such
loss, theft, or destruction, upon delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company,
or, in the case of any such mutilation, upon surrender and cancellation of this Warrant, the Company, at its expense, will execute
and deliver, in lieu thereof, a new Warrant of like tenor.

 

    	-6-

    	 

    

 

(d)                
Cancellation; Payment of Expenses. Upon the
surrender of this Warrant in connection with any transfer, exchange, or replacement as provided in this Paragraph 7, this Warrant
shall be promptly canceled by the Company. The Company shall pay all taxes (other than securities transfer taxes) and all other
expenses (other than legal expenses, if any, incurred by the holder or transferees) and charges payable in connection with the
preparation, execution, and delivery of Warrants pursuant to this Paragraph 7.

 

(e)                
Register. The Company shall maintain, at its
principal executive offices (or such other office or agency of the Company as it may designate by notice to the holder hereof),
a register for this Warrant, in which the Company shall record the name and address of the person in whose name this Warrant has
been issued, as well as the name and address of each transferee and each prior owner of this Warrant.

 

(f)                 
Exercise or Transfer Without Registration.
If, at the time of the surrender of this Warrant in connection with any exercise, transfer, or exchange of this Warrant, this Warrant
(or, in the case of any exercise, the Warrant Shares issuable hereunder), shall not be registered under the Securities Act of 1933,
as amended (the “Securities Act”) and under applicable state securities or blue sky laws, the Company may require,
as a condition of allowing such exercise, transfer, or exchange, (i) that the holder or transferee of this Warrant, as the case
may be, furnish to the Company a written opinion of counsel, which opinion and counsel are acceptable to the Company, to the effect
that such exercise, transfer, or exchange may be made without registration under said Act and under applicable state securities
or blue sky laws, (ii) that the holder or transferee execute and deliver to the Company an investment letter in form and substance
acceptable to the Company and (iii) that the transferee be an “accredited investor” as defined in Rule 501(a) promulgated
under the Securities Act; provided that no such opinion, letter or status as an “accredited investor” shall be required
in connection with a transfer pursuant to Rule 144 under the Securities Act. The first holder of this Warrant, by taking and holding
the same, represents to the Company that such holder is acquiring this Warrant not with a view to the distribution thereof.

 

	 	8.	Notices.

 

All notices, requests, and other communications
required or permitted to be given or delivered hereunder to the holder of this Warrant shall be in writing, and shall be personally
delivered, or shall be sent by certified or registered mail or by recognized overnight mail courier, postage prepaid and addressed,
to such holder at the address shown for such holder on the books of the Company, or at such other address as shall have been furnished
to the Company by notice from such holder. All notices, requests, and other communications required or permitted to be given or
delivered hereunder to the Company shall be in writing, and shall be personally delivered, or shall be sent by certified or registered
mail or by recognized overnight mail courier, postage prepaid and addressed, to the office of the Company at 575 Madison Avenue,
New York, NY 10022, Attention: Chief Executive Officer, or at such other address as shall have been furnished to the holder of
this Warrant by notice from the Company. Any such notice, request, or other communication may be sent by facsimile, but shall in
such case be subsequently confirmed by a writing personally delivered or sent by certified or registered mail or by recognized
overnight mail courier as provided above. All notices, requests, and other communications shall be deemed to have been given either
at the time of the receipt thereof by the person entitled to receive such notice at the address of such person for purposes of
this Paragraph 9, or, if mailed by registered or certified mail or with a recognized overnight mail courier upon deposit with the
United States Post Office or such overnight mail courier, if postage is prepaid and the mailing is properly addressed, as the case
may be.

 

    	-7-

    	 

    

 

	 	9.	Governing Law.

 

THIS WARRANT SHALL BE ENFORCED, GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN
SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES OF CONFLICT OF LAWS. THE PARTIES HERETO HEREBY SUBMIT TO THE EXCLUSIVE JURISDICTION
OF THE UNITED STATES FEDERAL COURTS LOCATED IN NEW YORK, NEW YORK WITH RESPECT TO ANY DISPUTE ARISING UNDER THIS WARRANT, THE AGREEMENTS
ENTERED INTO IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. BOTH PARTIES IRREVOCABLY WAIVE THE DEFENSE
OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH SUIT OR PROCEEDING. BOTH PARTIES FURTHER AGREE THAT SERVICE OF PROCESS UPON
A PARTY MAILED BY FIRST CLASS MAIL SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON THE PARTY IN ANY SUCH SUIT
OR PROCEEDING. NOTHING HEREIN SHALL AFFECT EITHER PARTY’S RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. BOTH
PARTIES AGREE THAT A FINAL NON-APPEALABLE JUDGMENT IN ANY SUCH SUIT OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER
JURISDICTIONS BY SUIT ON SUCH JUDGMENT OR IN ANY OTHER LAWFUL MANNER. THE PARTY WHICH DOES NOT PREVAIL IN ANY DISPUTE ARISING UNDER
THIS WARRANT SHALL BE RESPONSIBLE FOR ALL FEES AND EXPENSES, INCLUDING ATTORNEYS’ FEES, INCURRED BY THE PREVAILING PARTY
IN CONNECTION WITH SUCH DISPUTE.

 

		10.	Miscellaneous.

 

(a)                
Amendments. This Warrant and any provision
hereof may only be amended by an instrument in writing signed by the Company and the holder hereof.

 

(b)                
Descriptive Headings. The descriptive headings
of the several paragraphs of this Warrant are inserted for purposes of reference only, and shall not affect the meaning or construction
of any of the provisions hereof.

 

    	-8-

    	 

    

 

(c)                
Cashless Exercise. Notwithstanding anything
to the contrary contained in this Warrant, if the resale of the Warrant Shares by the holder is not then registered pursuant to
an effective registration statement under the Securities Act, this Warrant may be exercised by presentation and surrender of this
Warrant to the Company at its principal executive offices with a written notice of the holder’s intention to effect a cashless
exercise, including a calculation of the number of shares of Common Stock to be issued upon such exercise in accordance with the
terms hereof (a “Cashless Exercise”). In the event of a Cashless Exercise, in lieu of paying the Exercise Price in
cash, the holder shall surrender this Warrant for that number of shares of Common Stock determined by multiplying the number of
Warrant Shares to which it would otherwise be entitled by a fraction, the numerator of which shall be the difference between the
then current Market Price per share of the Common Stock and the Exercise Price, and the denominator of which shall be the then
current Market Price per share of Common Stock. For example, if the holder is exercising 100,000 Warrants with a per Warrant exercise
price of $0.75 per share through a cashless exercise when the Common Stock’s current Market Price per share is $2.00 per
share, then upon such Cashless Exercise the holder will receive 62,500 shares of Common Stock.

 

(d)                
Remedies. The Company acknowledges that a
breach by it of its obligations hereunder will cause irreparable harm to the holder, by vitiating the intent and purpose of the
transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under
this Warrant will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this
Warrant, that the holder shall be entitled, in addition to all other available remedies at law or in equity, and in addition to
the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this Warrant and
to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without any bond or
other security being required.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    	-9-

    	 

    

 

IN WITNESS WHEREOF, the Company has caused
this Warrant to be signed by its duly authorized officer.

 

	 	VANTAGE HEALTH
	 	 	 
	 	By:	/s/
    J. Jeremy Barbera
	 	 	J. Jeremy Barbera
	 	 	Chairman and Chief Executive Officer

 

Dated as of : December 16, 2013

 

    	 

    	 

    

 

FORM OF EXERCISE AGREEMENT

 

Dated: ___________

 

To: ______________________

 

 

The undersigned, pursuant to the provisions set
forth in the within Warrant, hereby agrees to purchase ________ shares of Common Stock covered by such Warrant, and makes payment
herewith in full therefor at the price per share provided by such Warrant in cash or by certified or official bank check in the
amount of, or, if the resale of such Common Stock by the undersigned is not currently registered pursuant to an effective registration
statement under the Securities Act of 1933, as amended, by surrender of securities issued by the Company (including a portion of
the Warrant) having a market value (in the case of a portion of this Warrant, determined in accordance with Section 10(c) of the
Warrant) equal to $_________. Please issue a certificate or certificates for such shares of Common Stock in the name of and pay
any cash for any fractional share to:

 

	 	Name:	 
	 	 	 
	 	Signature:	 
	 	Address:	 
	 	 	 
	 	 	 
	 	Note:	The above signature should correspond exactly with the
name on the face of the within Warrant, if applicable.

 

and, if said number of shares of Common Stock
shall not be all the shares purchasable under the within Warrant, a new Warrant is to be issued in the name of said undersigned
covering the balance of the shares purchasable thereunder less any fraction of a share paid in cash.

 

    	 

    	 

    

 

FORM OF ASSIGNMENT

 

FOR VALUE RECEIVED, the undersigned
hereby sells, assigns, and transfers all the rights of the undersigned under the within Warrant, with respect to the number of
shares of Common Stock covered thereby set forth herein below, to:

 

	Name
    of Assignee	 	Address	 	No
    of Shares
	 	 	 	 	 

 , and hereby irrevocably constitutes and appoints
___________________________________ as agent and attorney-in-fact to transfer said Warrant on the books of the within-named corporation,
with full power of substitution in the premises.

 

Dated: ______________

 

	In the presence of:	 	 
	 	Name:	 
	 	 	 
	 	Signature:	 
	 	Title of Signing Officer or Agent (if any):
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	Note:	The above signature should correspond exactly with the name on the face of the within Warrant, if applicable.INDEMNIFICATION
AGREEMENT

 

This
Indemnification Agreement (this “Agreement”) is dated as of 16 December 2013, and is between Vantage
Health, Inc., a Nevada corporation (the “Company”), and William S. Rees, Jr. (“Indemnitee”).

 

RECITALS

 

		A.	Indemnitee’s
                                         service to the Company substantially benefits the Company.

 

		B.	Individuals
                                         are reluctant to serve as directors or officers of corporations or in certain other capacities
                                         unless they are provided with adequate protection through insurance or indemnification
                                         against the risks of claims and actions against them arising out of such service.

 

		C.	Indemnitee
                                         does not regard the protection currently provided by applicable law, the Company’s
                                         governing documents, and any insurance as adequate under the present circumstances, and
                                         Indemnitee may not be willing to serve as a director or officer without additional protection.

 

		D.	In
                                         order to induce Indemnitee to continue to provide services to the Company, it is reasonable,
                                         prudent, and necessary for the Company to contractually obligate itself to indemnify,
                                         and to advance expenses on behalf of, Indemnitee as permitted by applicable law.

 

		E.	This
                                         Agreement is a supplement to and in furtherance of the indemnification provided in the
                                         Company’s certificate of incorporation and bylaws, and any resolutions adopted
                                         pursuant thereto, and this Agreement shall not be deemed a substitute therefor, nor shall
                                         this Agreement be deemed to limit, diminish or abrogate any rights of Indemnitee thereunder.

 

The
parties therefore agree as follows:

 

 1. Definitions.

 

		(a)	A
                                         “Change in Control” shall be deemed to occur upon the earliest
                                         to occur after the date of this Agreement of any of the following events:

 

(i)
Acquisition of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below),
directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of
the Company’s then outstanding securities;

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 1/18

    	 

    

  

(ii)
Change in Board Composition. During any period of two consecutive years (not including any period prior to the execution
of this Agreement), individuals who at the beginning of such period constitute the Company’s board of directors, and any
new directors (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction
described in Sections 1(a)(i), 1(a)(iii) or 1(a)(iv)) whose election by the board of directors or nomination for election by the
Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were
directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any
reason to constitute at least a majority of the members of the Company’s board of directors;

 

(iii)
Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than
a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger
or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the
surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately
after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing
body of such surviving entity;

 

(iv)
Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for
the sale or disposition by the Company of all or substantially all of the Company’s assets; and

 

(v)
Other Events. Any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A
of Regulation 14A (or in response to any similar item on any similar schedule or form) promulgated under the Securities Exchange
Act of 1934, as amended, whether or not the Company is then subject to such reporting requirement.

 

For
purposes of this Section 1(a), the following terms shall have the following meanings:

 

		(1)	“Person”
                                         shall have the meaning as set forth in Sections 13(d) and 14(d) of the Securities Exchange
                                         Act of 1934, as amended; provided, however, that “Person”
                                         shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities
                                         under an employee benefit plan of the Company, and (iii) any corporation owned, directly
                                         or indirectly, by the stockholders of the Company in substantially the same proportions
                                         as their ownership of stock of the Company.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 2/18

    	 

    

  

		(2)	“Beneficial
                                         Owner” shall have the meaning given to such term in Rule 13d-3 under the
                                         Securities Exchange Act of 1934, as amended; provided, however, that “Beneficial
                                         Owner” shall exclude any Person otherwise becoming a Beneficial Owner by
                                         reason of (i) the stockholders of the Company approving a merger of the Company with
                                         another entity or (ii) the Company’s board of directors approving a sale of securities
                                         by the Company to such Person.

 

(b)
“Corporate Status” describes the status of a person who is or was a director, trustee, general partner,
managing member, officer, employee, agent or fiduciary of the Company or any other Enterprise.

 

(c)
“NGCL” means the General Corporation Law of the State of Nevada.

 

(d)
“Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding
in respect of which indemnification is sought by Indemnitee.

 

(e)
“Enterprise” means the Company and any other corporation, partnership, limited liability company, joint
venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company
as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary.

 

(f)
“Expenses” include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees
and costs of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage,
delivery service fees, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting,
defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating
in, a Proceeding or responding to, or objecting to, a request to provide discovery in any Proceeding. Expenses also include (i)
Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security
for, and other costs relating to any cost bond, supersedes bond or other appeal bond or their equivalent, and (ii) for purposes
of Section 12(d), Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s
rights under this Agreement or under any directors’ and officers’ liability insurance policies maintained by the Company.
Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 3/18

    	 

    

 

(g)
“Independent Counsel” means a law firm, or a partner or member of a law firm, that is experienced in
matters of corporation law and neither presently is, nor in the past five years has been, retained to represent (i) the Company
or Indemnitee in any matter material to either such party (other than as Independent Counsel with respect to matters concerning
Indemnitee under this Agreement, or other indemnitees under similar indemnification agreements), or (ii) any other party to the
Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent
Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing,
would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s
rights under this Agreement. The Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to
fully indemnify such counsel against any and all Expenses, claims, liabilities, and damages arising out of or relating to this
Agreement or its engagement pursuant hereto.

 

(h)
“Proceeding” means any threatened, pending or completed action, suit, arbitration, mediation, alternate
dispute resolution mechanism, investigation, inquiry, administrative hearing or proceeding or any other actual, threatened, or
completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative
or investigative nature, including any appeal therefrom and including without limitation any such Proceeding pending as of the
date of this Agreement, in which Indemnitee was, is or will be involved as a party, a potential party, a non-party witness or
otherwise by reason of (i) the fact that Indemnitee is or was a director or officer of the Company, (ii) any action taken by Indemnitee
or any action or inaction on Indemnitee’s part while acting as a director or officer of the Company, or (iii) the fact that
he or she is or was serving at the request of the Company as a director, trustee, general partner, managing member, officer, employee,
agent or fiduciary of the Company or any other Enterprise, in each case whether or not serving in such capacity at the time any
liability or Expense is incurred for which indemnification or advancement of expenses can be provided under this Agreement.

 

(i)
Reference to “other enterprises” shall include employee benefit plans; references to “fines”
shall include any excise taxes assessed on a person with respect to any employee benefit plan; references to “serving
at the request of the Company” shall include any service as a director, officer, employee or agent of the Company
which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit
plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he or she reasonably believed to
be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a
manner “not opposed to the best interests of the Company” as referred to in this Agreement.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 4/18

    	 

    

  

2.
Indemnity in Third-Party Proceedings. The Company shall indemnify Indemnitee in accordance with the provisions of this
Section 2 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding
by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 2, Indemnitee shall be indemnified
to the fullest extent permitted by applicable law against all Expenses, judgments, penalties, fines and amounts paid in settlement
actually and reasonably incurred by Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue
or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to
the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe that
his or her conduct was unlawful.

 

3.
Indemnity in Proceedings by or in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the
provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or
in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified to
the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner
he or she reasonably believed to be in or not opposed to the best interests of the Company. If applicable law so provides, no
indemnification for Expenses shall be made under this Section 3 in respect of any claim, issue or matter as to which Indemnitee
shall have been adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that
the Nevada Court of Chancery or any court in which the Proceeding was brought shall determine upon application that, despite the
adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification
for such expenses as the Nevada Court of Chancery or such other court shall deem proper.

 

4.
Indemnification for Expenses of a Party Who is Wholly or Partly Successful. To the extent that Indemnitee is a party to
or a participant in and is successful (on the merits or otherwise) in defense of any Proceeding or any claim, issue or matter
therein, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection therewith. To the extent permitted by applicable law, if Indemnitee is not wholly successful in such Proceeding
but is successful, on the merits or otherwise, in defense of one or more but less than all claims, issues or matters in such Proceeding,
the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s
behalf in connection with each successfully resolved claim, issue or matter. For purposes of this section, and without limitation,
the termination of any claim, issue, or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to
be a successful result as to such claim, issue, or matter.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 5/18

    	 

    

  

5.
Indemnification for Expenses of a Witness. To the extent that Indemnitee is, by reason of his or her Corporate Status,
a witness, or is made (or asked) to respond to discovery requests, in any Proceeding to which Indemnitee is not a party, Indemnitee
shall be indemnified to the extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee
or on Indemnitee’s behalf in connection therewith.

 

6.
Additional Indemnification.

 

(a)
Notwithstanding any limitation in Sections 2, 3 or 4, the Company shall indemnify Indemnitee to the fullest extent permitted by
applicable law if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding (including a Proceeding
by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and amounts paid
in settlement actually and reasonably incurred by Indemnitee or on his or her behalf in connection with the Proceeding or any
claim, issue or matter therein.

 

(b)
For purposes of Section 6(a), the meaning of the phrase “to the fullest extent permitted by applicable law”
shall include, but not be limited to:

 

(i)
the fullest extent permitted by the provision of the NGCL that authorizes or contemplates additional indemnification by agreement,
or the corresponding provision of any amendment to or replacement of the NGCL; and

 

(ii)
the fullest extent authorized or permitted by any amendments to or replacements of the NGCL adopted after the date of this Agreement
that increase the extent to which a corporation may indemnify its officers and directors.

 

7.
Exclusions. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to
make any indemnity in connection with any Proceeding (or any part of any Proceeding):

 

(a)
for which payment has actually been made to or on behalf of Indemnitee under any statute, insurance policy, indemnity provision,
vote or otherwise, except with respect to any excess beyond the amount paid;

 

(b)
for an accounting or disgorgement of profits pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, or
similar provisions of federal, state or local statutory law or common law, if Indemnitee is held liable therefor;

 

(c)
for any reimbursement of the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any
profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Securities Exchange
Act of 1934, as amended (including any such reimbursements that arise from an accounting restatement of the Company pursuant to
Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company
of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act),
if Indemnitee is held liable therefor;

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 6/18

    	 

    

  

(d)
initiated by Indemnitee and not by way of defense, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee
against the Company or its directors, officers, employees, agents or other indemnitees, unless (i) the Company’s board of
directors authorized the Proceeding (or the relevant part of the Proceeding) prior to its initiation, (ii) the Company provides
the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law, (iii) otherwise
authorized in Section 12(d) or (iv) otherwise required by applicable law; or

 

(e)
if prohibited by applicable law.

 

8.
Advances of Expenses.

 

The
Company shall advance the Expenses incurred by Indemnitee in connection with any Proceeding prior to its final resolution, and
such advancement shall be made as soon as reasonably practicable, but in any event no later than 30 days, after the receipt by
the Company of a written statement or statements requesting such advances from time to time (which shall include invoices received
by Indemnitee in connection with such Expenses but, in the case of invoices in connection with legal services, any references
to legal work performed or to expenditure made that would cause Indemnitee to waive any privilege accorded by applicable law shall
not be included with the invoice). Advances shall be unsecured and interest free and made without regard to Indemnitee’s
ability to repay such advances. Indemnitee hereby undertakes to repay any advance to the extent that it is ultimately determined
that Indemnitee is not entitled to be indemnified by the Company. This Section 8 shall not apply to the extent advancement is
prohibited by law and shall not apply to any Proceeding for which indemnity is not permitted under this Agreement, but shall apply
to any Proceeding referenced in Section 7(b) or 7(c) prior to a determination that Indemnitee is not entitled to be indemnified
by the Company.

 

9.
Procedures for Notification and Defense of Claim.

 

(a)
It is the intent of this Agreement to secure for Indemnitee rights of indemnification that are as favorable as may be permitted
under the NGCL and public policy of the State of Nevada. Indemnitee shall notify the Company in writing of any matter with respect
to which Indemnitee intends to seek indemnification or advancement of Expenses as soon as reasonably practicable following the
receipt by Indemnitee of notice thereof. The written notification to the Company shall include, in reasonable detail, a description
of the nature of the Proceeding and the facts underlying the Proceeding. The failure by Indemnitee to notify the Company will
not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, except
to the extent that such failure or delay materially prejudices the Company.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 7/18

    	 

    

  

(b)
If, at the time of the receipt of a notice of a Proceeding pursuant to the terms hereof, the Company has directors’ and
officers’ liability insurance in effect, the Company shall give prompt notice of the commencement of the Proceeding to the
insurers in accordance with the procedures set forth in the applicable policies. The Company shall thereafter take all commercially-reasonable
action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable because of such Proceeding in accordance with
the terms of such policies.

 

(c)
In the event the Company may be obligated to make any indemnity in connection with a Proceeding, the Company shall be entitled
to assume the defense of such Proceeding with counsel approved by Indemnitee, which approval shall not be unreasonably withheld.
After the retention of such counsel by the Company, the Company will not be liable to Indemnitee for any fees or expenses of counsel
subsequently incurred by Indemnitee with respect to the same Proceeding. Notwithstanding the Company’s assumption of the
defense of any such Proceeding, the Company shall be obligated to pay the fees and expenses of Indemnitee’s separate counsel
to the extent (i) the employment of separate counsel by Indemnitee is authorized by the Company, (ii) counsel for the Company
or Indemnitee shall have reasonably concluded that there is a conflict of interest between the Company and Indemnitee in the conduct
of any such defense such that Indemnitee needs to be represented separately from the Company, (iii) the Company is not financially
or legally able to perform its indemnification obligations, or (iv) the Company shall not have retained, or shall not continue
to retain, such counsel to defend such Proceeding. In the event (x) the Indemnitee is entitled, pursuant to the preceding sentence,
to engage separate counsel at the Company’s expense to defend a Proceeding, and (y) there are other directors, officers,
employees or agents of the Company who are also defending the same Proceeding and who are also entitled to engage separate counsel
at the Company’s expense pursuant indemnification agreements or otherwise, then the Company will only be obligated to pay
for one counsel to represent all such indemnitees jointly, subject to the proviso that if counsel for the indemnitees shall have
reasonably concluded that there is a conflict of interest between or among the indemnitees in the conduct of their defense such
that one or more of the indemnitees must be represented separately from the other indemnitees, then the Company shall be obligated
to pay the fees and expenses of such separate representation. The Company shall have the right to conduct such defense as it sees
fit in its sole discretion. Regardless of any provision in this Agreement, Indemnitee shall have the right to employ counsel in
any Proceeding at Indemnitee’s personal expense. The Company shall not be entitled, without the consent of Indemnitee, to
assume the defense of any claim brought by or in the right of the Company.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 8/18

    	 

    

  

(d)
Indemnitee shall give the Company such information and cooperation in connection with the Proceeding as may be reasonably appropriate.

 

(e)
The Company shall not be liable to indemnify Indemnitee for any settlement of any Proceeding (or any part thereof) without the
Company’s prior written consent, which shall not be unreasonably withheld.

 

(f)
The Company shall not settle any Proceeding (or any part thereof) in a manner that imposes any penalty or liability on Indemnitee
without Indemnitee’s prior written consent, which may be withheld by Indemnitee in Indemnitee’s sole discretion.

  

10.
Procedures upon Application for Indemnification.

 

(a)
To obtain indemnification, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation
and information as is reasonably available to Indemnitee and as is reasonably necessary to determine whether and to what extent
Indemnitee is entitled to indemnification following the final disposition of the Proceeding. Any delay in providing the request
will not relieve the Company from its obligations under this Agreement, except to the extent such failure is materially prejudicial.

 

(b)
Upon written request by Indemnitee for indemnification pursuant to Section 10(a), a determination with respect to Indemnitee’s
entitlement thereto shall be made in the specific case (i) if a Change in Control shall have occurred, by Independent Counsel
in a written opinion to the Company’s board of directors, a copy of which shall be delivered to Indemnitee or (ii) if a
Change in Control shall not have occurred, if required by applicable law (A) by a majority vote of the Disinterested Directors,
even though less than a quorum of the Company’s board of directors, (B) by a committee of Disinterested Directors designated
by a majority vote of the Disinterested Directors, even though less than a quorum of the Company’s board of directors, (C)
if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written
opinion to the Company’s board of directors, a copy of which shall be delivered to Indemnitee or (D) if so directed by the
Company’s board of directors, by the stockholders of the Company. If it is determined that Indemnitee is entitled to indemnification,
payment to Indemnitee shall be made within ten days after such determination. Indemnitee shall cooperate with the person, persons
or entity making the determination with respect to Indemnitee’s entitlement to indemnification, including providing to such
person, persons or entity upon reasonable advance request any documentation or information that is not privileged or otherwise
protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs
or expenses (including attorneys’ fees and disbursements) reasonably incurred by Indemnitee in so cooperating with the person,
persons or entity making such determination shall be borne by the Company, to the extent permitted by applicable law.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 9/18

    	 

    

  

(c)
In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 10(b),
the Independent Counsel shall be selected as provided in this Section 10(c). If a Change in Control shall not have occurred, the
Independent Counsel shall be selected by the Company’s board of directors, and the Company shall give written notice to
Indemnitee advising him or her of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred,
the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Company’s
board of directors, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company
advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may
be, may, within ten days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee,
as the case may be, a written objection to such selection; provided, however, that such objection may be asserted
only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel”
as defined in Section 1 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.
Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so
made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection
is withdrawn or a court has determined that such objection is without merit. If, within 20 days after the later of (i) submission
by Indemnitee of a written request for indemnification pursuant to Section 10(a) hereof and (ii) the final disposition of the
Proceeding, the parties have not agreed upon an Independent Counsel, either the Company or Indemnitee may petition a court of
competent jurisdiction for resolution of any objection which shall have been made by the Company or Indemnitee to the other’s
selection of Independent Counsel and for the appointment as Independent Counsel of a person selected by the court or by such other
person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed
shall act as Independent Counsel under Section 10(b) hereof. Upon the due commencement of any judicial proceeding or arbitration
pursuant to Section 12(a) of this Agreement, the Independent Counsel shall be discharged and relieved of any further responsibility
in such capacity (subject to the applicable standards of professional conduct then prevailing). The Company shall pay the reasonable
fees and expenses of any Independent Counsel.

 

11.
Presumptions and Effect of Certain Proceedings.

 

(a)
In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such
determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under
this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that
presumption.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 10/18

    	 

    

  

(b)
The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon
a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or
not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause
to believe that his or her conduct was unlawful.

 

(c)
Neither the knowledge, actions nor failure to act of any other director, officer, agent or employee of the Enterprise shall be
imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

 

12.
Remedies of Indemnitee.

 

(a)
Subject to Section 12(e), in the event that (i) a determination is made pursuant to Section 10 of this Agreement that Indemnitee
is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 8
or 12(d) of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section
10 of this Agreement within 90 days after the later of the receipt by the Company of the request for indemnification or the final
disposition of the Proceeding, (iv) payment of indemnification pursuant to this Agreement is not made (A) within ten days after
a determination has been made that Indemnitee is entitled to indemnification or (B) with respect to indemnification pursuant to
Sections 4, 5 and 12(d) of this Agreement, within 30 days after receipt by the Company of a written request therefor, or (v) the
Company or any other person or entity takes or threatens to take any action to declare this Agreement void or unenforceable, or
institutes any litigation or other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided
or intended to be provided to Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by a court of competent jurisdiction
of his or her entitlement to such indemnification or advancement of Expenses. Alternatively, Indemnitee, at his or her option,
may seek an award in arbitration with respect to his or her entitlement to such indemnification or advancement of Expenses, to
be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee
shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which
Indemnitee first has the right to commence such proceeding pursuant to this Section 12(a); provided, however, that the
foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his or her rights under Section 4
of this Agreement. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration
in accordance with this Agreement.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 11/18

    	 

    

  

(b)
Neither (i) the failure of the Company, its board of directors, any committee or subgroup of the board of directors, Independent
Counsel or stockholders to have made a determination that indemnification of Indemnitee is proper in the circumstances because
Indemnitee has met the applicable standard of conduct, nor (ii) an actual determination by the Company, its board of directors,
any committee or subgroup of the board of directors, Independent Counsel or stockholders that Indemnitee has not met the applicable
standard of conduct, shall create a presumption that Indemnitee has or has not met the applicable standard of conduct. In the
event that a determination shall have been made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to indemnification,
any judicial proceeding or arbitration commenced pursuant to this Section 12 shall be conducted in all respects as a de novo
trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by reason of that adverse determination. In any
judicial proceeding or arbitration commenced pursuant to this Section 12, the Company shall, to the fullest extent not prohibited
by law, have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.

 

(c)
To the fullest extent not prohibited by law, the Company shall be precluded from asserting in any judicial proceeding or arbitration
commenced pursuant to this Section 12 that the procedures and presumptions of this Agreement are not valid, binding and enforceable
and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.
If a determination shall have been made pursuant to Section 10 of this Agreement that Indemnitee is entitled to indemnification,
the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section
12, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
statements not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification
under applicable law.

 

(d)
To the extent not prohibited by law, the Company shall indemnify Indemnitee against all Expenses that are incurred by Indemnitee
in connection with any action for indemnification or advancement of Expenses from the Company under this Agreement or under any
directors’ and officers’ liability insurance policies maintained by the Company to the extent Indemnitee is successful
in such action, and, if requested by Indemnitee, shall (as soon as reasonably practicable, but in any event no later than 60 days,
after receipt by the Company of a written request therefor) advance such Expenses to Indemnitee, subject to the provisions of
Section 8. Such advances shall be subject to Indemnitee’s agreement to repay the sums advanced if the court (or arbitrator)
finds that each material argument or defense advanced by Indemnitee in such action or arbitration was either frivolous or not
made in good faith.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 12/18

    	 

    

  

(e)
Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification shall be required
to be made prior to the final disposition of the Proceeding.

 

13.
Contribution.

 

(a)
Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason, Indemnitee
shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action,
suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding),
the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably
incurred and paid or payable by Indemnitee in proportion to the relative benefits received by the Company and all officers, directors
or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction or events from which such action,
suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit may, to the extent
necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors
or employees of the Company other than Indemnitee who are jointly liable with Indemnitee (or would be if joined in such action,
suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the transaction or events that resulted
in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations which applicable law may
require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than
Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand,
and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions
were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and
the degree to which their conduct is active or passive.

 

(b)
To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to
Indemnitee, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amounts incurred by Indemnitee, whether for
Expenses, judgments, fines or amounts paid or to be paid in settlement, in connection with any claim relating to an indemnifiable
event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding
in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the events and transactions
giving rise to such Proceeding; and (ii) the relative fault of Indemnitee and the Company (and its other directors, officers,
employees and agents) in connection with such events and transactions.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 13/18

    	 

    

  

(c)
The Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought
by officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee.

 

14.
Non-exclusivity. The rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall
not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Company’s
certificate of incorporation or bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. To the
extent that a change in Nevada law, whether by statute or judicial decision, permits greater indemnification or advancement of
Expenses than would be afforded currently under the Company’s certificate of incorporation and bylaws and this Agreement,
it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such
change, subject to the restrictions expressly set forth herein or therein. Except as expressly set forth herein, no right or remedy
herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative
and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.
Except as expressly set forth herein, the assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent
the concurrent assertion or employment of any other right or remedy.

 

15.
No Duplication of Payments. The Company shall not be liable under this Agreement to make any payment of amounts otherwise
indemnifiable hereunder (or for which advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually
received payment for such amounts under any insurance policy, contract, agreement or otherwise.

 

16.
Insurance. To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors,
trustees, general partners, managing members, officers, employees, agents or fiduciaries of the Company or any other Enterprise,
Indemnitee shall be covered by such policy or policies to the same extent as the most favorably-insured persons under such policy
or policies in a comparable position.

 

17.
Subrogation. In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment
to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure
such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 14/18

    	 

    

  

18.
Services to the Company. Indemnitee agrees to serve as a director or officer of the Company or, at the request of the Company,
as a director, trustee, general partner, managing member, officer, employee, agent or fiduciary of another Enterprise, for so
long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed from such position.
Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation
imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee
in such position. This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or
any Enterprise) and Indemnitee. Indemnitee specifically acknowledges that any employment with the Company (or any of its subsidiaries
or any Enterprise) is at will, and Indemnitee may be discharged at any time for any reason, with or without cause, with or without
notice, except as may be otherwise expressly provided in any executed, written employment contract between Indemnitee and the
Company (or any of its subsidiaries or any Enterprise), any existing formal severance policies adopted by the Company’s
board of directors or, with respect to service as a director or officer of the Company, the Company’s certificate of incorporation
or bylaws or the NGCL. No such document shall be subject to any oral modification thereof.

 

19.
Duration. This Agreement shall continue until and terminate upon the later of (a) ten years after the date that Indemnitee
shall have ceased to serve as a director or officer of the Company or as a director, trustee, general partner, managing member,
officer, employee, agent or fiduciary of any other Enterprise, as applicable; or (b) one year after the final termination of any
Proceeding, including any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement
of Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to Section 12 of this Agreement relating thereto.

 

20.
Successors. This Agreement shall be binding upon the Company and its successors and assigns, including any direct or indirect
successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company,
and shall inure to the benefit of Indemnitee and Indemnitee’s heirs, executors and administrators. The Company shall require
and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all
of the business or assets of the Company, by written agreement, expressly to assume and agree to perform this Agreement in the
same manner and to the same extent that the Company would be required to perform if no such succession had taken place.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 15/18

    	 

    

  

21.
Severability. Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or
fail to do any act in violation of applicable law. The Company’s inability, pursuant to court order or other applicable
law, to perform its obligations under this Agreement shall not constitute a breach of this Agreement. If any provision or provisions
of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality
and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any section of
this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal
or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted
by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to
give the maximum effect to the intent of the parties hereto; and (iii) to the fullest extent possible, the provisions of this
Agreement (including, without limitation, each portion of any section of this Agreement containing any such provision held to
be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect
to the intent manifested thereby.

 

22.
Enforcement. The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations
imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges
that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company.

 

23.
Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the subject
matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with
respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in furtherance
of the Company’s certificate of incorporation and bylaws and applicable law.

 

24.
Modification and Waiver. No supplement, modification, or amendment to this Agreement shall be binding unless executed in
writing by the parties hereto. No amendment, alteration or repeal of this Agreement shall adversely affect any right of Indemnitee
under this Agreement in respect of any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such
amendment, alteration or repeal. No waiver of any of the provisions of this Agreement shall constitute or be deemed a waiver of
any other provision of this Agreement nor shall any waiver constitute a continuing waiver.

 

25.
Notices. All notices and other communications required or permitted hereunder shall be in writing and shall be mailed by
registered or certified mail, postage prepaid, or otherwise delivered by hand, messenger or courier service addressed:

 

(a)
if to Indemnitee, to Indemnitee’s address, as shown on the signature page of this Agreement or in the Company’s records,
as may be updated in accordance with the provisions hereof; or

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 16/18

    	 

    

  

(b)
if to the Company, to the attention of the Chief Executive Officer of the Company at 2395 Broadway Street, Redwood City, California
94063, or at such other current address as the Company shall have furnished to Indemnitee.

 

Each
such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if
delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier
service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or (ii) if
sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle
for the deposit of the United States mail, addressed and mailed as aforesaid.

 

26.
Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed
by, and construed and enforced in accordance with, the laws of the State of Nevada without regard to its conflict of laws rules.
Except with respect to any arbitration commenced by Indemnitee pursuant to Section 12(a) of this Agreement, or except as mutually
agreed by the parties in writing, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action
or proceeding arising out of or in connection with this Agreement shall be brought only in the State courts of Nevada, and not
in any other state or federal court in the United States of America, or any court in any other country, (ii) consent to submit
to the exclusive jurisdiction of the State courts of Nevada for purposes of any action or proceeding arising out of or in connection
with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the State courts of
Nevada, and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the State courts
of Nevada has been brought in an improper or inconvenient forum.

 

27.
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed
to be an original but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and
delivered by facsimile signature and in counterparts, each of which shall for all purposes be deemed to be an original but all
of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability
is sought needs to be produced to evidence the existence of this Agreement.

 

28.
Captions. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to
constitute part of this Agreement or to affect the construction thereof.

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 17/18

    	 

    

 

The
parties are signing this Indemnification Agreement as of the date stated in the introductory sentence.

 

VANTAGE
HEALTH, INC.

 

	(signature)	 
	 	 
	/s/ J.
    Jeremy Barbera	 
	Chairman
    and Chief Executive Officer	 
	 	 
	(Signature)	 
	 	 
	/s/ William
    S. Rees, Jr.	 
	 	 
	P.
    O. Box 1003	 
	McLean,
    VA 22101	 

 

    	Vantage Health, Inc. Board of Directors Indemnification Agreement with William S. Rees, Jr.	Page 18/18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]